| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |